Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player

Go back to Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.88 +0.32 (3.74%)
Previous Close $8.56    52 Week High $9.23 
Open $8.53    52 Week Low $1.16 
Day High $8.94    P/E N/A 
Day Low $8.53    EPS $-0.30 
Volume 8,409,084